Biểu đồ giá cổ phiếu ETON
ETON Tài chính
Eton Pharmaceuticals Inc
$30.15
-0.75%
$-0.23
Khi đóng cửa: May 06, 16:00:00 GMT-4
$30.95
2.65%
$0.8
Phiên trước giờ: May 07, 05:29:13 GMT-4
Quay lại
Eton Pharmaceuticals Inc (ETON) Tài chính
Thống kê chính
Giá đóng cửa trước
$30.38
Giá mở cửa
$30.8
Phạm vi ngày
$30.1 - $31.48
Phạm vi 52 tuần
$13.09 - $30.95
Khối lượng
482.1K
Khối lượng trung bình
319.1K
Tỷ suất cổ tức
--
EPS (TTM)
-0.17
Vốn hóa thị trường
$844.3M
ETON là gì?
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. The company is headquartered in Deer Park, Illinois and currently employs 31 full-time employees. The company went IPO on 2018-11-09. The firm has six commercial rare disease products: INCRELEX, ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. INCRELEX is a biologic product used to treat pediatric patients 2 years of age and older who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD). ALKINDI SPRINKLE is for the treatment of pediatric adrenocortical insufficiency. Carglumic Acid is for the treatment of hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. Betaine Anhydrous is for the treatment of homocystinuria. Nitisinone is for the treatment of hereditary tyrosinemia type 1 (HT-1). PKU GOLIKE is a medical formula for patients with phenylketonuria (PKU). Galzin, its product, is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease.
